Morgan Stanley
NUTX

Morgan Stanley’s Nutex Health NUTX Stock Holding History

Morgan Stanley’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.32M Sell
19,427
-23,071
-54% -$2.92M ﹤0.01% 4513
2026
Q1 		$4.04M Sell
42,498
-15,142
-26% -$1.86M ﹤0.01% 4287
2025
Q4 		$9.49M Sell
57,640
-63,161
-52% -$8.38M ﹤0.01% 3659
2025
Q3 		$12.5M Buy
120,801
+89,493
+286% +$8.78M ﹤0.01% 3345
2025
Q2 		$3.9M Buy
31,308
+29,434
+1,571% +$3.8M ﹤0.01% 4258
2025
Q1 		$88.1K Buy
1,874
+1,215
+184% +$59.3K ﹤0.01% 6076
2024
Q4 		$20.9K Buy
+659
New +$18.8K ﹤0.01% 6559
2024
Q3 		– Sell
-451
Closed -$2.68K – 8000
2024
Q2 		$2.68K Sell
451
-33
-7% -$238 ﹤0.01% 7012
2024
Q1 		$6.97K Buy
484
+47
+11% +$946 ﹤0.01% 6809
2023
Q4 		$11.8K Sell
437
-447
-51% -$13.9K ﹤0.01% 6597
2023
Q3 		$26.9K Sell
884
-425
-32% -$20.5K ﹤0.01% 6395
2023
Q2 		$82.8K Sell
1,309
-402
-23% -$34.5K ﹤0.01% 6025
2023
Q1 		$259K Buy
1,711
+793
+86% +$161K ﹤0.01% 5587
2022
Q4 		$262K Sell
918
-1,447
-61% -$278K ﹤0.01% 5558
2022
Q3 		$530K Buy
2,365
+1,416
+149% +$601K ﹤0.01% 5241
2022
Q2 		$459K Buy
+949
New +$1.12M ﹤0.01% 5463

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Morgan Stanley's NUTX Position: Q2 2026 in Review

Morgan Stanley reduced its Nutex Health (NUTX) stake by 54% in Q2 2026, selling an estimated $2.92M and leaving 19,427 shares worth $3.32M. The position accounts for ﹤0.01% of the portfolio, ranked #4513.

Morgan Stanley first reported a position in NUTX in Q2 2022 and has held it in 16 quarters since. The position peaked at $12.5M in Q3 2025. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Morgan Stanley held 19,427 shares of Nutex Health worth $3.32M as of Q2 2026.
  • Morgan Stanley sold 23,071 Nutex Health shares in Q2 2026, an estimated $2.92M.
  • Nutex Health made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4513 holding.
  • Morgan Stanley first reported a position in Nutex Health in Q2 2022 and has held it in 16 quarters since.
  • Morgan Stanley's Nutex Health position peaked at $12.5M in Q3 2025.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.